SSRIs antidepressant activity is influenced by Gβ3 variants

• 1 March 2003
• journal article
• clinical trial
• Published by Elsevier in European Neuropsychopharmacology
• Vol. 13  (2) , 117-122
• https://doi.org/10.1016/s0924-977x(02)00154-2

Abstract

Keywords

• PHARMACOGENETICS
• PAROXETINE
• FLUVOXAMINE
• MOOD DISORDERS
• ANTIDEPRESSANT TREATMENT